222 related articles for article (PubMed ID: 23536429)
1. Five-year outcomes of self-expanding nitinol stent implantation for chronic total occlusion of the superficial femoral and proximal popliteal artery.
Sakamoto Y; Hirano K; Iida O; Soga Y; Suzuki K; Muramatsu T; Tsukahara R
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E251-6. PubMed ID: 23536429
[TBL] [Abstract][Full Text] [Related]
2. Endovascular nitinol stenting for long occlusive disease of the superficial femoral artery in critical limb ischemia: a single-center, mid-term result.
Hu H; Zhang H; He Y; Jin W; Tian L; Chen X; Li M
Ann Vasc Surg; 2011 Feb; 25(2):210-6. PubMed ID: 21315233
[TBL] [Abstract][Full Text] [Related]
3. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
[TBL] [Abstract][Full Text] [Related]
4. Bare nitinol stent enabled recanalization of long-segment, chronic total occlusion of superficial femoral and adjacent proximal popliteal artery in diabetic patients presenting with critical limb ischemia.
Taneja M; Tay KH; Dewan A; Sebastian MG; Pasupathy S; Lin SE; Teo T; Lo R; Tan SG; Irani FG; Tan BS
Cardiovasc Revasc Med; 2010; 11(4):232-5. PubMed ID: 20934655
[TBL] [Abstract][Full Text] [Related]
5. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
[TBL] [Abstract][Full Text] [Related]
6. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
[TBL] [Abstract][Full Text] [Related]
7. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B
J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
[TBL] [Abstract][Full Text] [Related]
8. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
9. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
[TBL] [Abstract][Full Text] [Related]
10. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
[TBL] [Abstract][Full Text] [Related]
11. Superficial femoral artery TASC D Registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia.
Lichtenberg M; Stahlhoff W; Boese D
J Cardiovasc Surg (Torino); 2013 Aug; 54(4):433-9. PubMed ID: 24013531
[TBL] [Abstract][Full Text] [Related]
12. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
[TBL] [Abstract][Full Text] [Related]
13. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
[TBL] [Abstract][Full Text] [Related]
14. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
15. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up.
Donas KP; Torsello G; Schwindt A; Schönefeld E; Boldt O; Pitoulias GA
J Vasc Surg; 2010 Aug; 52(2):356-61. PubMed ID: 20541349
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
17. Primary stenting of the superficial femoral and popliteal artery.
Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
[TBL] [Abstract][Full Text] [Related]
18. Treatment for long-segment femoro-popliteal obstructions: initial experience with a 4-F compatible self-expanding nitinol stent and review of the literature.
Baumann F; Do DD; Willenberg T; Baumgartner I; Diehm N
J Cardiovasc Surg (Torino); 2012 Aug; 53(4):475-80. PubMed ID: 22854527
[TBL] [Abstract][Full Text] [Related]
19. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of SMART Versus Luminexx Nitinol Stent Implantation for Aortoiliac Artery Disease: A Propensity Score-Matched Multicenter Study.
Shintani Y; Soga Y; Takahara M; Iida O; Kawasaki D; Yamauchi Y; Suzuki K; Hirano K; Kawasaki T
Angiology; 2015 Oct; 66(9):875-81. PubMed ID: 25540332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
